2647-50-9 Usage
Description
Flubromazepam is a potent, long-acting designer benzodiazepine drug that is structurally related to Phenazepam. It possesses anxiolytic, anticonvulsant, muscle relaxant, and hypnotic properties. Flubromazepam is categorized as an analytical reference standard and has been detected in seized samples. It is known for its anxiolytic and sedative properties, and it is used in research and forensic applications. However, it also has a high addiction potential and risk of overdose.
Uses
Used in Pharmaceutical Industry:
Flubromazepam is used as a treatment for neurological disorders such as epilepsy, alcohol withdrawal, and insomnia. It helps alleviate symptoms and improve the quality of life for patients suffering from these conditions.
Used in Preoperative Medication:
Flubromazepam is used as a premedication before surgery due to its ability to augment the effects of anesthetics and reduce anxiety in patients. This helps ensure a smoother and more comfortable surgical experience.
Used in Forensic Analysis:
Flubromazepam is used as a starting material in calibrators and controls for various gas chromatography/mass spectrometry (GC/MS) or liquid chromatography/mass spectrometry (LC/MS) applications. This aids in the detection and analysis of the drug in forensic cases, clinical toxicology, and urine drug testing.
Used in Research and Development:
Flubromazepam serves as an important research compound for the development of new drugs and therapies related to its anxiolytic, anticonvulsant, muscle relaxant, and hypnotic properties. It helps scientists understand the mechanisms of action and potential applications in various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 2647-50-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,6,4 and 7 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 2647-50:
(6*2)+(5*6)+(4*4)+(3*7)+(2*5)+(1*0)=89
89 % 10 = 9
So 2647-50-9 is a valid CAS Registry Number.
2647-50-9Relevant articles and documents
Structure-Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin
Abdelkafi, Hajer,Michau, Aurélien,Pons, Valérie,Ngadjeua, Flora,Clerget, Alexandra,Ait Ouarab, Lilia,Buisson, David-Alexandre,Montoir, David,Caramelle, Lucie,Gillet, Daniel,Barbier, Julien,Cintrat, Jean-Christophe
, p. 8114 - 8133 (2020/09/21)
High-throughput screening has shown that Retro-1 inhibits ricin and Shiga toxins by diminishing their intracellular trafficking via the retrograde route, from early endosomes to the Golgi apparatus. To improve the activity of Retro-1, a structure-activity relationship (SAR) study was undertaken and yielded an analogue with a roughly 70-fold better half-maximal effective concentration (EC50) against Shiga toxin cytotoxicity measured in a cell protein synthesis assay.
Carboxamide GABAa ALPHA2 Modulators
-
Page/Page column 13, (2009/04/24)
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects
-
Page/Page column 30, (2008/06/13)
The present invention provides compositions and methods of using stereospecific benzodiazepine derivatives, their salts and prodrugs for the treatment of anxiolytic or convulsant disorders having the side effects of reduced alcohol craving in human alcoholics and a concomitant reduced sedative, hypnotic, muscle relaxant and ataxic side-effects. The invention further provides pharmaceutical compositions for treatment of anxiolytic and convulsant disorders in subjects in need thereof, comprising a compound, prodrug or a salt having a chemical structure represented by any one of Formula I-XXI and a pharmaceutically-acceptable carrier.